| Literature DB >> 32738429 |
Craig A Elmets1, Neil J Korman2, Elizabeth Farley Prater3, Emily B Wong4, Reena N Rupani5, Dario Kivelevitch6, April W Armstrong7, Cody Connor1, Kelly M Cordoro8, Dawn M R Davis9, Boni E Elewski1, Joel M Gelfand10, Kenneth B Gordon11, Alice B Gottlieb12, Daniel H Kaplan13, Arthur Kavanaugh14, Matthew Kiselica15, Daniela Kroshinsky16, Mark Lebwohl5, Craig L Leonardi17, Jason Lichten15, Henry W Lim18, Nehal N Mehta19, Amy S Paller20, Sylvia L Parra21, Arun L Pathy22, Michael Siegel23, Benjamin Stoff24, Bruce Strober25, Jashin J Wu26, Vidhya Hariharan27, Alan Menter6.
Abstract
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.Entities:
Keywords: alternative medicine (AM); clinical guidelines for psoriasis; dermatology; guidelines; psoriasis; severity assessment; skin disease; topical agents
Mesh：
Substances：
Year: 2020 PMID： 32738429 DOI： 10.1016/j.jaad.2020.07.087
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527